Journal profile

Nanotheranostics

Publisher: Ivyspring International Publishers
ISSN2206-7418 FormatOnline StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.23
Citation rate 9.35 613 total citations
h5-index 35 h5 depth signal
Cited share 92.4% 61 of 66
Total citations 613 Citation footprint
Metric signal 7.17 External metric anchor
Self-citation 0.7% 4 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 90
China 64
India 47
United Kingdom 15
Canada 11

Citing Fields of Research

Nanoparticles 105
Drug Delivery Systems 102
Oncology 32
Diagnostic & Therapeutic Ultrasound 24
Biosensors 21

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 291 Articles tracked across the journal lifetime
Indexed publication set 66 61 cited publications
Last 12 months 19 2.1 publications/month
Open access share 94.7% 18 OA publications in the last year
Leading citing country United States 90 citing publications
Leading citing field Nanoparticles 105 citing publications
Latest tracked publication 9 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v2n1, 2018-
PubMed
v1n1, 2017-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Drug Delivery Systems Nanoparticles Noncoding RNA Biosensors Medical Physics Oncology Diagnostic & Therapeutic Ultrasound

Broad Categories

Nanotechnology Nanoparticles Diagnostic & Therapeutic Ultrasound Noncoding RNA Polymer & Macromolecule Science Digestive Disorders Drug Delivery Systems

MeSH Descriptors

Theranostic Nanomedicine

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

05
Saikat Maiti, Maya Teitz, Esteban Velarde et al.
Rationale: Radiotherapy-induced brain injury (RIBI) is a chronic side effect, that affects up to ~90% of brain tumor survivors treated with radiotherapy. Chronic oxidative stress and neuroinflammation are key drivers of RIBI. Here, we de...

Bibliographical & Catalog Notes

Text and graphics.